3h Bio

Developer of drugs targeting metabolic diseases

placeSeongnam Si, Gyeonggi Do, South Korea calendar_todayFounded 2019 groups5 employees language threehbio.com

Innovation

4 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 121 times.

YearFilings
20211
20221
20232
20243
20251
20261

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon